Related Experiment Videos
Pitfalls in preoperative staging in prostate cancer
E Mukamel1, J Hanna, J B deKernion
1Department of Surgery/Urology, UCLA Medical Center.
Urology
|October 1, 1987
Summary
Accurate prostate cancer staging is crucial. Previous treatments like transurethral resection or irradiation can alter the prostate, leading to understaging in patients with advanced adenocarcinoma of the prostate.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Accurate clinical staging of prostate adenocarcinoma is essential for treatment planning.
- Understaging can lead to suboptimal therapeutic decisions and outcomes.
Purpose of the Study:
- To compare clinical and pathologic staging in prostate cancer patients.
- To identify factors contributing to staging errors, particularly understaging.
Main Methods:
- Retrospective analysis of 60 patients with adenocarcinoma of the prostate.
- Comparison of clinical staging with post-surgical pathologic staging.
- Evaluation of factors such as capsular invasion, seminal vesicle extension, and lymph node metastasis.
Main Results:
- Understaging rates increased with tumor stage: 0% for A2, 26.5% for B1, and 66.7% for B2.
- Higher rates of capsular invasion, seminal vesicle extension, and lymph node metastasis were observed in higher stage tumors.
- Previous treatments (transurethral resection, irradiation) were common in patients with unnoticed tumor extension.
Conclusions:
- Preoperative treatments can induce changes in the prostate, interfering with accurate clinical staging.
- Understaging is significantly associated with advanced tumor stage and previous interventions.
- Improved diagnostic methods are needed to account for treatment-induced changes in prostate cancer staging.